Trials in Tampa, Florida
Here are the top 10 medical studies for breast cancer in Tampa, Florida
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Trastuzumab Deruxtecan for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
Tampa, Florida
This trial will compare trastuzumab deruxtecan to other treatments for patients with HER2-low breast cancer that cannot be removed by surgery and has spread. The treatment targets and kills cancer cells by delivering chemotherapy directly to them. Trastuzumab deruxtecan has shown effectiveness in patients with HER2-low breast cancer, resulting in longer periods without the disease getting worse and longer life expectancy compared to other chemotherapy treatments.
PI3K Inhibitor
Inavolisib Combination for Breast Cancer
Recruiting0 awardsPhase 2 & 3
Saint Petersburg, Florida
This trial tests a new drug combination (inavolisib, palbociclib, and fulvestrant) for patients with a specific type of advanced breast cancer that got worse after hormone therapy. The treatment aims to stop cancer cells from growing and spreading by attacking them in different ways.
Trials With No Placebo
Small Molecule Inhibitor
CYT-0851 for Cancer
Recruiting3 awardsPhase 1 & 2
Sarasota, Florida
This trial is testing a new drug called CYT-0851 in patients with certain types of cancer that have not responded to other treatments. The goal is to see if the drug is safe and understand how it works in the body.
Monoclonal Antibodies
ABBV-927 + ABBV-181 + Nab-paclitaxel + ABBV-368 + Carboplatin for Solid Tumors
Recruiting1 awardPhase 1
Tampa, Florida
This trial is testing new drugs combined with chemotherapy to treat patients with certain types of solid tumors. It aims to understand how these treatments work together and their safety.
XL092 + Immunotherapy for Cancer
Recruiting1 awardPhase 1
Lake Mary, Florida
This trial is testing a new drug called XL092 by itself and with two other drugs, atezolizumab and avelumab. It targets patients with advanced solid tumors who may not respond to current treatments. XL092 aims to stop cancer cells from growing, while atezolizumab and avelumab help the immune system fight the cancer. Atezolizumab is approved for various cancers, including breast and urothelial carcinoma, and has shown efficacy in combination with chemotherapy.
Selective Estrogen Receptor Modulator
Lasofoxifene vs Fulvestrant for Breast Cancer
Recruiting3 awardsPhase 2
Winter Haven, Florida
This trial evaluates the activity of a drug (lasofoxifene) to treat pre- and postmenopausal women with advanced breast cancer caused by an ESR1 mutation. It will measure progression free survival, clinical benefit, response rate, overall survival, QoL and safety.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.